$PKTX
ProtoKinetix, Inc.

2022 Q4 Form 10-Q Financial Statement

#000107997322001380 Filed on October 31, 2022

View on sec.gov

Income Statement

Concept 2022 Q4 2022 Q3 2021 Q3
Revenue $0.00 $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $505.6K $208.3K $1.300M
YoY Change 143.11% -83.98% -15.81%
% of Gross Profit
Research & Development $21.91K $161.0K $100.9K
YoY Change -88.19% 59.57% -29.06%
% of Gross Profit
Depreciation & Amortization $56.20K $750.00 $750.00
YoY Change 7393.33% 0.0% 0.0%
% of Gross Profit
Operating Expenses $583.7K $370.0K $1.402M
YoY Change 48.08% -73.61% -16.92%
Operating Profit
YoY Change
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income -$583.7K -$370.0K -$1.402M
YoY Change 48.08% -73.61% -16.92%
Income Tax
% Of Pretax Income
Net Earnings -$583.7K -$370.0K -$1.402M
YoY Change 48.08% -73.61% -16.92%
Net Earnings / Revenue
Basic Earnings Per Share $0.00
Diluted Earnings Per Share $0.00 -$1.272K -$4.782K
COMMON SHARES
Basic Shares Outstanding 314.3M shares 309.5M shares
Diluted Shares Outstanding 291.0M shares

Balance Sheet

Concept 2022 Q4 2022 Q3 2021 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $25.55K $43.71K $145.3K
YoY Change -55.62% -69.92% 224.62%
Cash & Equivalents $25.55K $43.71K $145.3K
Short-Term Investments
Other Short-Term Assets $1.050K $1.050K $1.050K
YoY Change -95.96% 0.0% 0.0%
Inventory
Prepaid Expenses $1.050K $1.050K
Receivables
Other Receivables
Total Short-Term Assets $26.60K $44.76K $146.4K
YoY Change -68.17% -69.41% 219.47%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $436.3K $435.0K $339.4K
YoY Change 20.29% 28.15% 35.42%
TOTAL ASSETS
Total Short-Term Assets $26.60K $44.76K $146.4K
Total Long-Term Assets $436.3K $435.0K $339.4K
Total Assets $462.9K $479.7K $485.8K
YoY Change 3.73% -1.24% 63.86%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $41.53K $105.0K
YoY Change -55.47%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $41.53K $105.0K $7.000K
YoY Change -55.47% 1400.47% 40.0%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $41.53K $105.0K $7.000K
Total Long-Term Liabilities $0.00 $0.00 $0.00
Total Liabilities $41.53K $105.0K $7.000K
YoY Change -55.47% 1400.43% 40.0%
SHAREHOLDERS EQUITY
Retained Earnings -$47.45M -$46.86M
YoY Change 4.19%
Common Stock $1.726K $1.681K
YoY Change 8.49%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $421.3K $374.7K $478.8K
YoY Change
Total Liabilities & Shareholders Equity $462.9K $479.7K $485.8K
YoY Change 3.73% -1.24% 63.86%

Cashflow Statement

Concept 2022 Q4 2022 Q3 2021 Q3
OPERATING ACTIVITIES
Net Income -$583.7K -$370.0K -$1.402M
YoY Change 48.08% -73.61% -16.92%
Depreciation, Depletion And Amortization $56.20K $750.00 $750.00
YoY Change 7393.33% 0.0% 0.0%
Cash From Operating Activities -$147.2K -$157.5K -$157.0K
YoY Change -37.03% 0.38% -37.9%
INVESTING ACTIVITIES
Capital Expenditures $57.49K -$42.57K -$20.34K
YoY Change -339.44% 109.29% 98.44%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$57.49K -$42.57K -$20.34K
YoY Change 139.44% 109.29% 98.44%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 186.5K 225.0K 238.0K
YoY Change 9.71% -5.46% -9.32%
NET CHANGE
Cash From Operating Activities -147.2K -157.5K -157.0K
Cash From Investing Activities -57.49K -42.57K -20.34K
Cash From Financing Activities 186.5K 225.0K 238.0K
Net Change In Cash -18.16K 24.88K 60.70K
YoY Change -79.3% -59.01% -11136.36%
FREE CASH FLOW
Cash From Operating Activities -$147.2K -$157.5K -$157.0K
Capital Expenditures $57.49K -$42.57K -$20.34K
Free Cash Flow -$204.7K -$115.0K -$136.6K
YoY Change -2.41% -15.84% -43.66%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Central Index Key
EntityCentralIndexKey
0001128189
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
PKTX Issuance Of Common Stock Pursuant To Cashless Option Exercise Amount
IssuanceOfCommonStockPursuantToCashlessOptionExerciseAmount
usd
CY2021Q3 PKTX Issuance Of Common Stock Pursuant To Cashless Option Exercise Amount
IssuanceOfCommonStockPursuantToCashlessOptionExerciseAmount
usd
us-gaap Increase Decrease In Prepaid Expenses Other
IncreaseDecreaseInPrepaidExpensesOther
usd
us-gaap Interest Paid Net
InterestPaidNet
usd
us-gaap Interest Paid Net
InterestPaidNet
usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
usd
CY2022Q3 PKTX Deposit Shareholder Meeting
DepositShareholderMeeting
usd
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2022-09-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
000-32917
dei Entity Registrant Name
EntityRegistrantName
PROTOKINETIX, INCORPORATED
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
94-3355026
dei Entity Address Address Line1
EntityAddressAddressLine1
412 Mulberry St.
dei Entity Address City Or Town
EntityAddressCityOrTown
Marietta
dei Entity Address State Or Province
EntityAddressStateOrProvince
OH
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
45750
dei City Area Code
CityAreaCode
740
dei Local Phone Number
LocalPhoneNumber
434-5041
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2022Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
314330151 shares
CY2022Q3 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
43712 usd
CY2021Q4 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
57568 usd
CY2022Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
1050 usd
CY2021Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
25995 usd
CY2022Q3 us-gaap Assets Current
AssetsCurrent
44762 usd
CY2021Q4 us-gaap Assets Current
AssetsCurrent
83563 usd
CY2022Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
434977 usd
CY2021Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
362671 usd
CY2022Q3 us-gaap Assets
Assets
479739 usd
CY2021Q4 us-gaap Assets
Assets
446234 usd
PKTX Net Loss Per Common Share Basic And Diluted
NetLossPerCommonShareBasicAndDiluted
-0.01
CY2022Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
105033 usd
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
93268 usd
CY2022Q3 us-gaap Liabilities Current
LiabilitiesCurrent
105033 usd
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
93268 usd
CY2022Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0000053
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0000053
CY2022Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2022Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
314330151 shares
CY2022Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
314330151 shares
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
297393485 shares
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
297393485 shares
CY2022Q3 us-gaap Common Stock Value
CommonStockValue
1681 usd
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
1591 usd
CY2022Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
47237847 usd
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
45892545 usd
CY2022Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-46864822 usd
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-45541170 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
374706 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
352966 usd
CY2022Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
479739 usd
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
446234 usd
CY2022Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
750 usd
CY2021Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
750 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
2250 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
2250 usd
CY2022Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
31690 usd
CY2021Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
34346 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
146227 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
278308 usd
CY2022Q3 us-gaap Professional Fees
ProfessionalFees
33122 usd
CY2021Q3 us-gaap Professional Fees
ProfessionalFees
27397 usd
us-gaap Professional Fees
ProfessionalFees
121015 usd
us-gaap Professional Fees
ProfessionalFees
89479 usd
CY2022Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
160994 usd
CY2021Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
100888 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
426968 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
250419 usd
CY2022Q3 us-gaap Share Based Compensation
ShareBasedCompensation
143486 usd
CY2021Q3 us-gaap Share Based Compensation
ShareBasedCompensation
1238638 usd
us-gaap Share Based Compensation
ShareBasedCompensation
627192 usd
us-gaap Share Based Compensation
ShareBasedCompensation
1314700 usd
CY2022Q3 us-gaap Operating Expenses
OperatingExpenses
370042 usd
CY2021Q3 us-gaap Operating Expenses
OperatingExpenses
1402018 usd
us-gaap Operating Expenses
OperatingExpenses
1323652 usd
us-gaap Operating Expenses
OperatingExpenses
1935156 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-370042 usd
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-1402018 usd
us-gaap Net Income Loss
NetIncomeLoss
-1323652 usd
us-gaap Net Income Loss
NetIncomeLoss
-1935156 usd
CY2022Q3 PKTX Net Loss Per Common Share Basic And Diluted
NetLossPerCommonShareBasicAndDiluted
-0.01
CY2021Q3 PKTX Net Loss Per Common Share Basic And Diluted
NetLossPerCommonShareBasicAndDiluted
-0.01
PKTX Net Loss Per Common Share Basic And Diluted
NetLossPerCommonShareBasicAndDiluted
-0.01
CY2022Q3 PKTX Weighted Average Number Of Common Shares Outstanding Basic And Diluted
WeightedAverageNumberOfCommonSharesOutstandingBasicAndDiluted
290989603 shares
CY2021Q3 PKTX Weighted Average Number Of Common Shares Outstanding Basic And Diluted
WeightedAverageNumberOfCommonSharesOutstandingBasicAndDiluted
290414046 shares
PKTX Weighted Average Number Of Common Shares Outstanding Basic And Diluted
WeightedAverageNumberOfCommonSharesOutstandingBasicAndDiluted
299244493 shares
PKTX Weighted Average Number Of Common Shares Outstanding Basic And Diluted
WeightedAverageNumberOfCommonSharesOutstandingBasicAndDiluted
287443326 shares
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
352966 usd
us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
718200 usd
us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
627192 usd
us-gaap Profit Loss
ProfitLoss
-1323652 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
374706 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
376262 usd
CY2022Q3 us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
225000 usd
CY2022Q3 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
143486 usd
CY2022Q3 us-gaap Profit Loss
ProfitLoss
-370042 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
374706 usd
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
424221 usd
us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
415001 usd
PKTX Issuance Of Common Stock Pursuant To Warrant Exercise
IssuanceOfCommonStockPursuantToWarrantExercise
260000 usd
us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
1314700 usd
us-gaap Profit Loss
ProfitLoss
-1935156 usd
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
478766 usd
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
400475 usd
CY2021Q3 us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
168000 usd
CY2021Q3 PKTX Issuance Of Common Stock Pursuant To Warrant Exercise
IssuanceOfCommonStockPursuantToWarrantExercise
70000 usd
CY2021Q3 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
1238638 usd
CY2021Q3 us-gaap Profit Loss
ProfitLoss
-1402018 usd
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
478766 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-1323652 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-1935156 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
2250 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
2250 usd
PKTX Fair Value Of Compensatory Options Granted
FairValueOfCompensatoryOptionsGranted
627192 usd
PKTX Fair Value Of Compensatory Options Granted
FairValueOfCompensatoryOptionsGranted
1314700 usd
us-gaap Increase Decrease In Prepaid Expenses Other
IncreaseDecreaseInPrepaidExpensesOther
-24945 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
11765 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-37960 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-657500 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-656166 usd
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
74556 usd
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
66981 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-74556 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-66981 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
718200 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
675001 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
718200 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
675001 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-13856 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-48146 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
57568 usd
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
193445 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
43712 usd
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
145299 usd
CY2015 PKTX Payment To Acquire Intangible Assets
PaymentToAcquireIntangibleAssets
30000 usd
CY2015Q4 PKTX Additional Patent Applications
AdditionalPatentApplications
10000 usd
CY2015 PKTX Warrant Issued
WarrantIssued
6000000 shares
CY2015 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
25000 usd
us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_84A_eus-gaap--UseOfEstimates_zow5a0SYx3b5" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b><span style="text-decoration: underline"><span id="xdx_86E_zh4BKZSpOVni">Use of Estimates</span></span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and reported amounts of revenue and expenses during the reporting period.  Actual results could differ from those estimates.  The more significant accounting estimates inherent in the preparation of the Company’s financial statements include estimates as to valuation of equity related instruments issued, deferred income taxes, and the useful life and impairment of intangible assets.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p>
CY2022Q3 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
456727 usd
CY2020Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
16500 usd
CY2021 PKTX Amortization
Amortization
3000 usd
CY2022Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
434977 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
2250 usd
CY2021Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
19500 usd
PKTX Amortization
Amortization
2250 usd
CY2022Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
21750 usd
CY2021Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
362671 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
2250 usd
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
74556 usd
us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
627192 usd
us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
1314700 usd
CY2022Q3 us-gaap Deposits Assets
DepositsAssets
1050 usd
CY2021Q4 us-gaap Deposits Assets
DepositsAssets
1050 usd
CY2021Q4 PKTX Deposit Shareholder Meeting
DepositShareholderMeeting
24945 usd
CY2022Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
1050 usd
CY2021Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
25995 usd
CY2020Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
291186 usd
CY2021 us-gaap Payments To Acquire Other Productive Assets
PaymentsToAcquireOtherProductiveAssets
90985 usd
CY2021Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
382171 usd
us-gaap Payments To Acquire Other Productive Assets
PaymentsToAcquireOtherProductiveAssets
74556 usd
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0176 pure
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0176 pure
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.0000 pure
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.0000 pure
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
1.4070 pure
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
1.4070 pure
PKTX Expected Forfeiture Rate
ExpectedForfeitureRate
0.0000 pure
PKTX Expected Forfeiture Rate
ExpectedForfeitureRate
0.0000 pure
PKTX Sharebased Compensation Arrangement By Sharebased Paymenst Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymenstAwardFairValueAssumptionsExpectedTerm1
P8Y
PKTX Sharebased Compensation Arrangement By Sharebased Paymenst Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymenstAwardFairValueAssumptionsExpectedTerm1
P6Y
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
94690000 shares
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
92190000 shares
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
0 usd
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
2107500 usd
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
0.06
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
0.09
CY2022Q3 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
14800000 shares
CY2022Q3 PKTX Common Stock Shares Authorizeds
CommonStockSharesAuthorizeds
500000000 shares
CY2021Q4 PKTX Common Stock Shares Authorizeds
CommonStockSharesAuthorizeds
400000000 shares
CY2022Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0000053
CY2022Q3 us-gaap Dividends Receivable
DividendsReceivable
0 usd
CY2021Q4 us-gaap Dividends Receivable
DividendsReceivable
0 usd
us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
555556 shares
us-gaap Related Party Transaction Amounts Of Transaction
RelatedPartyTransactionAmountsOfTransaction
45000 usd
us-gaap Related Party Transaction Amounts Of Transaction
RelatedPartyTransactionAmountsOfTransaction
45000 usd
us-gaap Allocated Share Based Compensation Expense Net Of Tax
AllocatedShareBasedCompensationExpenseNetOfTax
435202 usd
us-gaap Allocated Share Based Compensation Expense Net Of Tax
AllocatedShareBasedCompensationExpenseNetOfTax
649822 usd
CY2022Q3 us-gaap Related Party Deposit Liabilities
RelatedPartyDepositLiabilities
0 usd
CY2021Q4 us-gaap Related Party Deposit Liabilities
RelatedPartyDepositLiabilities
0 usd

Files In Submission

Name View Source Status
0001079973-22-001380-index-headers.html Edgar Link pending
0001079973-22-001380-index.html Edgar Link pending
0001079973-22-001380.txt Edgar Link pending
0001079973-22-001380-xbrl.zip Edgar Link pending
ex31x1.htm Edgar Link pending
ex31x2.htm Edgar Link pending
ex32.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
pktx-20220930.xsd Edgar Link pending
pktx_10q-093022.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
pktx-20220930_def.xml Edgar Link unprocessable
pktx-20220930_cal.xml Edgar Link unprocessable
pktx-20220930_lab.xml Edgar Link unprocessable
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
pktx-20220930_pre.xml Edgar Link unprocessable
pktx_10q-093022_htm.xml Edgar Link completed